NIH #1R43GM154542-01
Chemically Induced Dimerization Systems for High Throughput Enzyme Assays
- Amount
- $271K
- Period
- 2024-09-20 → 2026-06-19
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R21AI160508-01
Targeting a Human Acyltransferase for Broad-Spectrum Antivirals
- Amount
- $391K
- Period
- 2021-08-01 → 2024-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #5R44AI141281-03
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases
- Amount
- $832K
- Period
- 2019-06-12 → 2023-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #2R44AI141281-02
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases
- Amount
- $989K
- Period
- 2019-06-12 → 2023-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R43CA254590-01A1
Discovery of TREX1 Antagonists for Cancer Immunotherapy
- Amount
- $300K
- Period
- 2020-09-11 → 2022-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #3R44GM123833-03S1
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
- Amount
- $329K
- Period
- 2017-05-01 → 2021-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #5R44GM123833-03
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
- Amount
- $416K
- Period
- 2017-05-01 → 2021-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R43AI141281-01A1
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases
- Amount
- $300K
- Period
- 2019-06-12 → 2021-02-16
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #2R44GM123833-02
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
- Amount
- $592K
- Period
- 2017-05-01 → 2020-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #5R44GM109621-03
Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery
- Amount
- $390K
- Period
- 2014-07-15 → 2020-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R41GM121123-01
Streamlining HTS Assay Development through Direct Selection of Structure-Switching Aptamers
- Amount
- $235K
- Period
- 2016-09-13 → 2019-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R43AA025498-01
Pharmacological Validation of GIV/Girdin, a Guanine Nucleotide Exchange Factor, for Liver Fibrosis
- Amount
- $353K
- Period
- 2016-09-20 → 2018-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R43GM123833-01
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
- Amount
- $289K
- Period
- 2017-05-01 → 2018-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #2R44GM109621-02
Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery
- Amount
- $470K
- Period
- 2014-07-15 → 2018-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R41NS090693-01
Axonal Transport HTS Platform for Neurodegeneration Drug Discovery
- Amount
- $225K
- Period
- 2015-06-01 → 2017-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R43NS089394-01A1
Fluorescent biosensors for dynamic monitoring of paracrine signaling in extracellular matrix
- Amount
- $225K
- Period
- 2015-04-01 → 2016-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #5K12HL108974-02
Oregon Multidisciplinary Training Program in Emergency Medicine Clinical Research
- Amount
- $535K
- Period
- 2011-07-01 → 2016-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #1K12HL108974-01
Oregon Multidisciplinary Training Program for Emergency Medicine Clinical Researc
- Amount
- $216K
- Period
- 2011-07-01 → 2016-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #1R43GM109621-01
Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery
- Amount
- $225K
- Period
- 2014-07-15 → 2016-01-14
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #2R15GM075960-03
Mechanism Based Design of Ce(IV) Mediated Reactions
- Amount
- $334K
- Period
- 2006-02-02 → 2015-08-14
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at LEHIGH UNIVERSITY
NIH #261201400010C-0-0-1
Replicating Tumor ECM in Microchannels for 3D Phenotypic HTS Assays
- Amount
- $225K
- Period
- 2014-09-12 → 2015-06-11
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #5R44HL103079-03
Screening Device for Differentiated Primary Cell Models of Airway Epithelia
- Amount
- $194K
- Period
- 2010-04-01 → 2014-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #2R44HL103079-02
Screening Device for Differentiated Primary Cell Models of Airway Epithelia
- Amount
- $540K
- Period
- 2010-04-01 → 2014-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1RC4DA029988-01
Building an Evidence Base for Treating the Vulnerable: A Community Partnership
- Amount
- $400K
- Period
- 2010-09-30 → 2013-09-29
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #1R43GM101771-01
High Throughput Assay for Detecting Protein Modifications in Cell Lysates
- Amount
- $272K
- Period
- 2011-09-26 → 2013-09-25
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #5U10NS058940-05
Brain Research/Acute Interventions: Neurological Emergencies Treatment Trials
- Amount
- $194K
- Period
- 2007-09-30 → 2012-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #5U10NS058940-04
Brain Research/Acute Interventions: Neurological Emergencies Treatment Trials
- Amount
- $194K
- Period
- 2007-09-30 → 2012-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #1R43GM095124-01
Intramolecular Immunoassay for Probing Paracrine Signaling
- Amount
- $251K
- Period
- 2010-09-01 → 2012-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #5U10NS058940-03
Brain Research/Acute Interventions: Neurological Emergencies Treatment Trials
- Amount
- $194K
- Period
- 2007-09-30 → 2012-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #5U10NS058940-02
Brain Research/Acute Interventions: Neurological Emergencies Treatment Trials
- Amount
- $194K
- Period
- 2007-09-30 → 2012-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #1U10NS058940-01
Brain Research/Acute Interventions: Neurological Emergencies Treatment Trials
- Amount
- $334K
- Period
- 2007-09-30 → 2012-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #5R44NS059082-03
HTS Assays for Modulators of GPCR Signaling
- Amount
- $701K
- Period
- 2007-09-01 → 2011-11-28
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #2R15GM075960-02A1
Mechanism Based Design of Ce(IV) Mediated Reactions
- Amount
- $227K
- Period
- 2006-02-02 → 2011-08-14
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at LEHIGH UNIVERSITY
NIH #5R44GM073290-03
Fluorescent HTS Assays for Methyltransferases in Neurodegenerative Diseases
- Amount
- $459K
- Period
- 2006-09-15 → 2011-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #2R44NS059082-02
HTS Assays for Modulators of GPCR Signaling
- Amount
- $672K
- Period
- 2007-09-01 → 2011-02-28
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R43GM088945-01
Enhanced ADP Immunoassay for Multimode Kinase Detection
- Amount
- $193K
- Period
- 2009-08-01 → 2011-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #2R44GM073290-02
Fluorescent HTS Assays for Methyltransferases in Neurodegenerative Diseases
- Amount
- $363K
- Period
- 2006-09-15 → 2010-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R43GM083478-01
Generic Fluorescent HTS Assay for Oxidoreductases
- Amount
- $210K
- Period
- 2008-02-01 → 2009-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #5R44CA110535-03
Generic Fluorescent HTS Assay for Kinases and ATPases
- Amount
- $258K
- Period
- 2005-07-01 → 2008-09-29
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #2R44CA110535-02
Generic Fluorescent HTS Assay for Kinases and ATPases
- Amount
- $391K
- Period
- 2005-07-01 → 2008-09-29
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R43NS059082-01
HTS Assays for Modulators of GPCR Signaling
- Amount
- $235K
- Period
- 2007-09-01 → 2008-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #1R43GM073290-01A1
Fluorescent HTS Assay for Methyltransferases in Neurodegenerative Diseases
- Amount
- $163K
- Period
- 2006-09-15 → 2007-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC
NIH #5R44GM069258-03
Fluorescent HTS Assays for Human Sulfotransferases
- Amount
- $476K
- Period
- 2003-07-01 → 2007-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BELLBROOK LABS, LLC